Enfortumab Vedotin–related Cutaneous Toxicity and Radiographic Response in Patients with Urothelial Cancer: A Single-center Experience and Review of the Literature
Author:
Publisher
Elsevier BV
Subject
Urology
Reference10 articles.
1. The biology and rationale of targeting nectin-4 in urothelial carcinoma;Heath;Nat Rev Urol,2020
2. Enfortumab vedotin antibody-drug conjugate targeting nectin-4 is a highly potent therapeutic agent in multiple preclinical cancer models;Challita-Eid;Cancer Res,2016
3. Enfortumab vedotin in previously treated advanced urothelial carcinoma;Powles;N Engl J Med,2021
4. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV–201): a multicentre, single-arm, phase 2 trial;Yu;Lancet Oncol,2021
5. Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy;Rosenberg;J Clin Oncol,2019
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database;Heliyon;2024-09
2. The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies;Critical Reviews in Oncology/Hematology;2024-08
3. Dermatologic toxicities of antibody-drug conjugates;Journal of the American Academy of Dermatology;2024-08
4. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18
5. Enfortumab vedotin‐induced cutaneous eruption: Ring mitotic figures as a distinctive histopathologic feature;Journal of Cutaneous Pathology;2024-07-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3